ID   FKBP4_HUMAN             Reviewed;         459 AA.
AC   Q02790; D3DUQ1; Q9UCP1; Q9UCV7;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 196.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP4;
DE            Short=PPIase FKBP4;
DE            EC=5.2.1.8;
DE   AltName: Full=51 kDa FK506-binding protein;
DE            Short=FKBP51;
DE   AltName: Full=52 kDa FK506-binding protein;
DE            Short=52 kDa FKBP;
DE            Short=FKBP-52;
DE   AltName: Full=59 kDa immunophilin;
DE            Short=p59;
DE   AltName: Full=FK506-binding protein 4;
DE            Short=FKBP-4;
DE   AltName: Full=FKBP59;
DE   AltName: Full=HSP-binding immunophilin;
DE            Short=HBI;
DE   AltName: Full=Immunophilin FKBP52;
DE   AltName: Full=Rotamase;
DE   Contains:
DE     RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed;
GN   Name=FKBP4; Synonyms=FKBP52;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=1279700; DOI=10.1073/pnas.89.22.10974;
RA   Peattie D.A., Harding M.W., Fleming M.A., Decenzo M.T., Lippke J.A.,
RA   Livingston D.J., Benasutti M.;
RT   "Expression and characterization of human FKBP52, an immunophilin that
RT   associates with the 90-kDa heat shock protein and is a component of
RT   steroid receptor complexes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10974-10978(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-28; 40-73; 75-121; 139-152; 158-179; 187-206;
RP   211-250; 257-274; 277-313; 319-354; 359-399; 409-426 AND 446-459,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Lourenco F., Olson M.F.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-25, SUBUNIT, AND FUNCTION.
RC   TISSUE=Thymus;
RX   PubMed=1376003; DOI=10.1126/science.1376003;
RA   Tai P.-K.K., Albers M.W., Chang H., Faber L.E., Schreiber S.L.;
RT   "Association of a 59-kilodalton immunophilin with the glucocorticoid
RT   receptor complex.";
RL   Science 256:1315-1318(1992).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-21, FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RC   TISSUE=Lymphocyte;
RX   PubMed=2378870; DOI=10.1021/bi00473a021;
RA   Sanchez E.R., Faber L.E., Henzel W.J., Pratt W.B.;
RT   "The 56-59-kilodalton protein identified in untransformed steroid
RT   receptor complexes is a unique protein that exists in cytosol in a
RT   complex with both the 70- and 90-kilodalton heat shock proteins.";
RL   Biochemistry 29:5145-5152(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-18.
RC   TISSUE=T-cell;
RX   PubMed=1371107;
RA   Yem A.W., Tomasselli A.G., Heinrikson R.L., Zurcher-Neely H.,
RA   Ruff V.A., Johnson R.A., Deibel M.R. Jr.;
RT   "The Hsp56 component of steroid receptor complexes binds to
RT   immobilized FK506 and shows homology to FKBP-12 and FKBP-13.";
RL   J. Biol. Chem. 267:2868-2871(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 16-32, AND SUBUNIT.
RX   PubMed=1383226;
RA   Wiederrecht G., Hung S., Chan H.K., Marcy A., Martin M., Calaycay J.,
RA   Boulton D., Sigal N., Kincaid R.L., Siekierka J.J.;
RT   "Characterization of high molecular weight FK-506 binding activities
RT   reveals a novel FK-506-binding protein as well as a protein complex.";
RL   J. Biol. Chem. 267:21753-21760(1992).
RN   [10]
RP   TERNARY COMPLEX WITH HSP90; HSP70 AND NR3C2, AND DISSOCIATION UPON
RP   ALDOSTERONE BINDING.
RX   PubMed=9392437;
RA   Bruner K.L., Derfoul A., Robertson N.M., Guerriero G.,
RA   Fernandes-Alnemri T., Alnemri E.S., Litwack G.;
RT   "The unliganded mineralocorticoid receptor is associated with heat
RT   shock proteins 70 and 90 and the immunophilin FKBP-52.";
RL   Recept. Signal Transduct. 7:85-98(1997).
RN   [11]
RP   INTERACTION WITH HSF1.
RX   PubMed=11583998; DOI=10.1074/jbc.M105931200;
RA   Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O.,
RA   Smith D.F., Voellmy R.;
RT   "Evidence for a mechanism of repression of heat shock factor 1
RT   transcriptional activity by a multichaperone complex.";
RL   J. Biol. Chem. 276:45791-45799(2001).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451 AND SER-453, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-453, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   INTERACTION WITH TRPC1, FUNCTION, AND MUTAGENESIS OF 67-PHE-ASP-68.
RX   PubMed=19945390; DOI=10.1016/j.neuron.2009.09.025;
RA   Shim S., Yuan J.P., Kim J.Y., Zeng W., Huang G., Milshteyn A.,
RA   Kern D., Muallem S., Ming G.L., Worley P.F.;
RT   "Peptidyl-prolyl isomerase FKBP52 controls chemotropic guidance of
RT   neuronal growth cones via regulation of TRPC1 channel opening.";
RL   Neuron 64:471-483(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-282, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   INTERACTION WITH S100A1; S100A2 AND S100A6.
RX   PubMed=20188096; DOI=10.1016/j.febslet.2010.02.055;
RA   Shimamoto S., Kubota Y., Tokumitsu H., Kobayashi R.;
RT   "S100 proteins regulate the interaction of Hsp90 with cyclophilin 40
RT   and FKBP52 through their tetratricopeptide repeats.";
RL   FEBS Lett. 584:1119-1125(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   SUBCELLULAR LOCATION, FUNCTION, AND INTERACTION WITH GLUCOCORTICOID
RP   RECEPTOR.
RX   PubMed=21730050; DOI=10.1074/jbc.M111.256610;
RA   Gallo L.I., Lagadari M., Piwien-Pilipuk G., Galigniana M.D.;
RT   "The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is
RT   a mitochondrial protein that translocates to the nucleus to protect
RT   cells against oxidative stress.";
RL   J. Biol. Chem. 286:30152-30160(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451 AND SER-453, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-220 AND THR-436, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-441, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 2-139.
RX   PubMed=12499534;
RA   Li P., Ding Y., Wu B., Shu C., Shen B., Rao Z.;
RT   "Structure of the N-terminal domain of human FKBP52.";
RL   Acta Crystallogr. D 59:16-22(2003).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2-458 IN COMPLEX WITH HSP90,
RP   AND SUBUNIT.
RX   PubMed=15159550; DOI=10.1073/pnas.0305969101;
RA   Wu B., Li P., Liu Y., Lou Z., Ding Y., Shu C., Ye S., Bartlam M.,
RA   Shen B., Rao Z.;
RT   "3D structure of human FK506-binding protein 52: implications for the
RT   assembly of the glucocorticoid receptor/Hsp90/immunophilin
RT   heterocomplex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8348-8353(2004).
CC   -!- FUNCTION: Immunophilin protein with PPIase and co-chaperone
CC       activities. Component of steroid receptors heterocomplexes through
CC       interaction with heat-shock protein 90 (HSP90). May play a role in
CC       the intracellular trafficking of heterooligomeric forms of steroid
CC       hormone receptors between cytoplasm and nuclear compartments. The
CC       isomerase activity controls neuronal growth cones via regulation
CC       of TRPC1 channel opening. Acts also as a regulator of microtubule
CC       dynamics by inhibiting MAPT/TAU ability to promote microtubule
CC       assembly. May have a protective role against oxidative stress in
CC       mitochondria. {ECO:0000269|PubMed:1279700,
CC       ECO:0000269|PubMed:1376003, ECO:0000269|PubMed:19945390,
CC       ECO:0000269|PubMed:21730050, ECO:0000269|PubMed:2378870}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Inhibited by FK506.
CC       {ECO:0000269|PubMed:1279700}.
CC   -!- SUBUNIT: Homodimer (By similarity). Associates with HSP90AA1 and
CC       HSP70 in steroid hormone receptor complexes. Also interacts with
CC       peroxisomal phytanoyl-CoA alpha-hydroxylase (PHYH). Interacts with
CC       NR3C1 and dynein. Interacts with HSF1 in the HSP90 complex.
CC       Associates with tubulin. Interacts with MAPT/TAU. Interacts (via
CC       TPR domain) with S100A1, S100A2 and S100A6; the interaction is
CC       Ca(2+) dependent. Interaction with S100A1 and S100A2 (but not with
CC       S100A6) leads to inhibition of FKBP4-HSP90 interaction. Interacts
CC       with dynein; causes partially NR3C1 transport to the nucleus.
CC       {ECO:0000250, ECO:0000269|PubMed:11583998,
CC       ECO:0000269|PubMed:1376003, ECO:0000269|PubMed:1383226,
CC       ECO:0000269|PubMed:15159550, ECO:0000269|PubMed:19945390,
CC       ECO:0000269|PubMed:20188096, ECO:0000269|PubMed:21730050,
CC       ECO:0000269|PubMed:2378870}.
CC   -!- INTERACTION:
CC       Q9UKV8:AGO2; NbExp=2; IntAct=EBI-1047444, EBI-528269;
CC       Q16543:CDC37; NbExp=3; IntAct=EBI-1047444, EBI-295634;
CC       Q92990:GLMN; NbExp=3; IntAct=EBI-1047444, EBI-726150;
CC       P07900:HSP90AA1; NbExp=8; IntAct=EBI-1047444, EBI-296047;
CC       P04792:HSPB1; NbExp=2; IntAct=EBI-1047444, EBI-352682;
CC       P35467:S100a1 (xeno); NbExp=7; IntAct=EBI-1047444, EBI-6477109;
CC       P29034:S100A2; NbExp=3; IntAct=EBI-1047444, EBI-752230;
CC       P06703:S100A6; NbExp=3; IntAct=EBI-1047444, EBI-352877;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:2378870}. Mitochondrion
CC       {ECO:0000269|PubMed:21730050}. Nucleus
CC       {ECO:0000250|UniProtKB:P30416}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q9QVC8}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q9QVC8}. Note=Shuttles from mitochondria to
CC       nucleus; co-localizes in mitochondria with the glucocorticoid
CC       receptor (PubMed:21730050). Colocalized with MAPT/TAU in the
CC       distal part of the primary cortical neurons (By similarity).
CC       {ECO:0000250|UniProtKB:Q9QVC8, ECO:0000269|PubMed:21730050}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:1279700}.
CC   -!- DOMAIN: The PPIase activity is mainly due to the fisrt PPIase
CC       FKBP-type domain (1-138 AA). {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal region (AA 375-458) is required to prevent
CC       tubulin polymerization. {ECO:0000250}.
CC   -!- DOMAIN: The chaperone activity resides in the C-terminal region,
CC       mainly between amino acids 264 and 400. {ECO:0000250}.
CC   -!- DOMAIN: The TPR repeats mediate mitochondrial localization.
CC   -!- PTM: Phosphorylation by CK2 results in loss of HSP90 binding
CC       activity. {ECO:0000250}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=A mind astray - Issue
CC       118 of June 2010;
CC       URL="http://web.expasy.org/spotlight/back_issues/118";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M88279; AAA36111.1; -; mRNA.
DR   EMBL; AC005841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88889.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88890.1; -; Genomic_DNA.
DR   EMBL; BC001786; AAH01786.1; -; mRNA.
DR   EMBL; BC007924; AAH07924.1; -; mRNA.
DR   CCDS; CCDS8512.1; -.
DR   PIR; A46372; A46372.
DR   RefSeq; NP_002005.1; NM_002014.3.
DR   UniGene; Hs.524183; -.
DR   UniGene; Hs.713721; -.
DR   PDB; 1N1A; X-ray; 2.40 A; A/B=1-140.
DR   PDB; 1P5Q; X-ray; 2.80 A; A/B/C=146-459.
DR   PDB; 1Q1C; X-ray; 1.90 A; A=2-260.
DR   PDB; 1QZ2; X-ray; 3.00 A; A/B/C=145-459.
DR   PDB; 4DRJ; X-ray; 1.80 A; A=1-140.
DR   PDB; 4LAV; X-ray; 1.80 A; A/B=16-260.
DR   PDB; 4LAW; X-ray; 2.40 A; A/B=16-260.
DR   PDB; 4LAX; X-ray; 2.01 A; A=16-260.
DR   PDB; 4LAY; X-ray; 1.70 A; A=1-260.
DR   PDB; 4TW8; X-ray; 3.00 A; A/B=21-255.
DR   PDBsum; 1N1A; -.
DR   PDBsum; 1P5Q; -.
DR   PDBsum; 1Q1C; -.
DR   PDBsum; 1QZ2; -.
DR   PDBsum; 4DRJ; -.
DR   PDBsum; 4LAV; -.
DR   PDBsum; 4LAW; -.
DR   PDBsum; 4LAX; -.
DR   PDBsum; 4LAY; -.
DR   PDBsum; 4TW8; -.
DR   ProteinModelPortal; Q02790; -.
DR   SMR; Q02790; -.
DR   BioGrid; 108578; 84.
DR   DIP; DIP-50866N; -.
DR   IntAct; Q02790; 57.
DR   MINT; MINT-3024864; -.
DR   STRING; 9606.ENSP00000001008; -.
DR   BindingDB; Q02790; -.
DR   ChEMBL; CHEMBL4050; -.
DR   iPTMnet; Q02790; -.
DR   PhosphoSitePlus; Q02790; -.
DR   SwissPalm; Q02790; -.
DR   BioMuta; FKBP4; -.
DR   DMDM; 399866; -.
DR   REPRODUCTION-2DPAGE; IPI00219005; -.
DR   EPD; Q02790; -.
DR   MaxQB; Q02790; -.
DR   PaxDb; Q02790; -.
DR   PeptideAtlas; Q02790; -.
DR   PRIDE; Q02790; -.
DR   DNASU; 2288; -.
DR   Ensembl; ENST00000001008; ENSP00000001008; ENSG00000004478.
DR   GeneID; 2288; -.
DR   KEGG; hsa:2288; -.
DR   UCSC; uc001qkz.4; human.
DR   CTD; 2288; -.
DR   DisGeNET; 2288; -.
DR   GeneCards; FKBP4; -.
DR   H-InvDB; HIX0010330; -.
DR   HGNC; HGNC:3720; FKBP4.
DR   HPA; CAB017441; -.
DR   HPA; HPA006148; -.
DR   HPA; HPA062857; -.
DR   MalaCards; FKBP4; -.
DR   MIM; 600611; gene.
DR   neXtProt; NX_Q02790; -.
DR   OpenTargets; ENSG00000004478; -.
DR   PharmGKB; PA28161; -.
DR   eggNOG; KOG0543; Eukaryota.
DR   eggNOG; COG0545; LUCA.
DR   GeneTree; ENSGT00760000119159; -.
DR   HOGENOM; HOG000256916; -.
DR   HOVERGEN; HBG051624; -.
DR   InParanoid; Q02790; -.
DR   KO; K09571; -.
DR   OMA; HPTDTEM; -.
DR   OrthoDB; EOG091G07OA; -.
DR   PhylomeDB; Q02790; -.
DR   TreeFam; TF354214; -.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   SIGNOR; Q02790; -.
DR   ChiTaRS; FKBP4; human.
DR   EvolutionaryTrace; Q02790; -.
DR   GeneWiki; FKBP52; -.
DR   GenomeRNAi; 2288; -.
DR   PRO; PR:Q02790; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000004478; -.
DR   CleanEx; HS_FKBP4; -.
DR   ExpressionAtlas; Q02790; baseline and differential.
DR   Genevisible; Q02790; HS.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0032767; F:copper-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0005528; F:FK506 binding; TAS:UniProtKB.
DR   GO; GO:0035259; F:glucocorticoid receptor binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.
DR   GO; GO:0030674; F:protein binding, bridging; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB.
DR   GO; GO:0006825; P:copper ion transport; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0046661; P:male sex differentiation; IEA:Ensembl.
DR   GO; GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl.
DR   GO; GO:0031111; P:negative regulation of microtubule polymerization or depolymerization; ISS:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0030850; P:prostate gland development; IEA:Ensembl.
DR   GO; GO:0031503; P:protein complex localization; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006463; P:steroid hormone receptor complex assembly; IEA:Ensembl.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR031212; FKBP4.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR001440; TPR_1.
DR   InterPro; IPR013105; TPR_2.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR10516; PTHR10516; 1.
DR   PANTHER; PTHR10516:SF332; PTHR10516:SF332; 1.
DR   Pfam; PF00254; FKBP_C; 2.
DR   Pfam; PF00515; TPR_1; 1.
DR   Pfam; PF07719; TPR_2; 1.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 2.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell projection; Chaperone;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Isomerase; Isopeptide bond; Methylation; Microtubule; Mitochondrion;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Rotamase; TPR repeat; Ubl conjugation.
FT   CHAIN         1    459       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP4.
FT                                /FTId=PRO_0000391468.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000269|PubMed:1371107,
FT                                ECO:0000269|PubMed:1376003,
FT                                ECO:0000269|PubMed:2378870,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    459       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP4, N-terminally processed.
FT                                /FTId=PRO_0000075318.
FT   DOMAIN       50    138       PPIase FKBP-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      167    253       PPIase FKBP-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   REPEAT      270    303       TPR 1.
FT   REPEAT      319    352       TPR 2.
FT   REPEAT      353    386       TPR 3.
FT   REGION      267    400       Interaction with tubulin. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine; in peptidyl-prolyl
FT                                cis-trans isomerase FKBP4; alternate.
FT                                {ECO:0000269|Ref.5}.
FT   MOD_RES       2      2       N-acetylthreonine; in peptidyl-prolyl
FT                                cis-trans isomerase FKBP4, N-terminally
FT                                processed; partial. {ECO:0000269|Ref.5}.
FT   MOD_RES     143    143       Phosphothreonine; by CK2. {ECO:0000250}.
FT   MOD_RES     220    220       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     282    282       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     373    373       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P30416}.
FT   MOD_RES     436    436       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     451    451       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     453    453       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   CROSSLNK    441    441       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   VARIANT     436    436       T -> P (in dbSNP:rs1042228).
FT                                /FTId=VAR_050624.
FT   MUTAGEN      67     68       FD->DV: Decreased catalytic activity
FT                                toward TRPC1.
FT                                {ECO:0000269|PubMed:19945390}.
FT   STRAND       22     24       {ECO:0000244|PDB:4DRJ}.
FT   STRAND       30     39       {ECO:0000244|PDB:4LAY}.
FT   STRAND       42     44       {ECO:0000244|PDB:4LAY}.
FT   STRAND       52     61       {ECO:0000244|PDB:4LAY}.
FT   STRAND       66     69       {ECO:0000244|PDB:4LAY}.
FT   HELIX        70     72       {ECO:0000244|PDB:4LAY}.
FT   STRAND       73     75       {ECO:0000244|PDB:4LAY}.
FT   STRAND       77     80       {ECO:0000244|PDB:4LAY}.
FT   STRAND       83     86       {ECO:0000244|PDB:4LAY}.
FT   HELIX        88     94       {ECO:0000244|PDB:4LAY}.
FT   STRAND      102    107       {ECO:0000244|PDB:4LAY}.
FT   HELIX       109    111       {ECO:0000244|PDB:4LAY}.
FT   TURN        112    116       {ECO:0000244|PDB:4LAY}.
FT   TURN        119    121       {ECO:0000244|PDB:4LAY}.
FT   STRAND      128    138       {ECO:0000244|PDB:4LAY}.
FT   STRAND      147    156       {ECO:0000244|PDB:4LAY}.
FT   STRAND      159    161       {ECO:0000244|PDB:4LAY}.
FT   STRAND      169    178       {ECO:0000244|PDB:4LAY}.
FT   STRAND      181    191       {ECO:0000244|PDB:4LAY}.
FT   TURN        192    194       {ECO:0000244|PDB:4LAW}.
FT   HELIX       195    198       {ECO:0000244|PDB:4LAY}.
FT   HELIX       202    208       {ECO:0000244|PDB:4LAY}.
FT   STRAND      216    221       {ECO:0000244|PDB:4LAY}.
FT   HELIX       223    225       {ECO:0000244|PDB:4LAY}.
FT   TURN        226    230       {ECO:0000244|PDB:4LAY}.
FT   HELIX       233    235       {ECO:0000244|PDB:4LAY}.
FT   STRAND      243    253       {ECO:0000244|PDB:4LAY}.
FT   HELIX       258    260       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       263    283       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       286    299       {ECO:0000244|PDB:1P5Q}.
FT   TURN        300    302       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       309    331       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       335    348       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       353    365       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       369    382       {ECO:0000244|PDB:1P5Q}.
FT   HELIX       387    424       {ECO:0000244|PDB:1P5Q}.
SQ   SEQUENCE   459 AA;  51805 MW;  6A498105418D9435 CRC64;
     MTAEEMKATE SGAQSAPLPM EGVDISPKQD EGVLKVIKRE GTGTEMPMIG DRVFVHYTGW
     LLDGTKFDSS LDRKDKFSFD LGKGEVIKAW DIAIATMKVG EVCHITCKPE YAYGSAGSPP
     KIPPNATLVF EVELFEFKGE DLTEEEDGGI IRRIQTRGEG YAKPNEGAIV EVALEGYYKD
     KLFDQRELRF EIGEGENLDL PYGLERAIQR MEKGEHSIVY LKPSYAFGSV GKEKFQIPPN
     AELKYELHLK SFEKAKESWE MNSEEKLEQS TIVKERGTVY FKEGKYKQAL LQYKKIVSWL
     EYESSFSNEE AQKAQALRLA SHLNLAMCHL KLQAFSAAIE SCNKALELDS NNEKGLFRRG
     EAHLAVNDFE LARADFQKVL QLYPNNKAAK TQLAVCQQRI RRQLAREKKL YANMFERLAE
     EENKAKAEAS SGDHPTDTEM KEEQKSNTAG SQSQVETEA
//
